Besides seriously undermining one of the world's most highly regarded regulatory agencies, stakeholders should consider the logical extension of this decision, not least for patient safety and public confidence in the health system. …
If this decision to undermine the TGA reflects a policy decision, be transparent about it
December 18, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
AusBiotech takes 15-year refund limit fight to the Senate as R&D tax bill lands
October 28, 2026 - - Latest News -
The stakes are very high on access in a contested budget environment
October 28, 2026 - - Latest News -
Managing an agreement negotiation as a 'prisoner of circumstance'
October 28, 2026 - - Latest News -
Lung scarring killing 11 Australians a day, with one in five cases traced to work
October 28, 2026 - - Latest News -
MSAC suggests minister skip HTA and make policy fix to ensure access to this technology
October 28, 2026 - - Latest News -
Company rebates fall for the first time in years, lifting net PBS costs
October 27, 2026 - - Latest News -
Access delayed - the stakes are high for the industry's next agreements
October 27, 2026 - - Latest News